According to SEC filings for the period ending December 2025, Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is held by 20 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 31 Dec, 2025 | 875,228 | 875,228 | 0.00% | $3,395,885.00 |
| Shay Capital LLC | 31 Dec, 2025 | 169,059 | 169,059 | 0.00% | $655,949.00 |
| AdvisorShares Investments LLC | 31 Dec, 2025 | 134,194 | 75,631 | 129.14% | $520,673.00 |
| DIADEMA PARTNERS LP | 31 Dec, 2025 | 50,000 | 28,548 | 133.08% | $194,000.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 30,000 | 30,000 | 0.00% | $116,400.00 |
| FNY Investment Advisers, LLC | 31 Dec, 2025 | 26,500 | 26,500 | 0.00% | $102.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 20,950 | 0 | 0.00% | $81,286.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 17,303 | 4,325 | 33.33% | $67,135.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 16,597 | 928 | 5.92% | $64,396.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 14,750 | 14,750 | 0.00% | $57,230.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 14,000 | 14,000 | 0.00% | $54,320.00 |
| Persistent Asset Partners Ltd | 31 Dec, 2025 | 13,403 | 8,495 | 173.08% | $52,004.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 12,008 | 12,008 | 0.00% | $46,591.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Dec, 2025 | 11,207 | 11,207 | 0.00% | $43,480.00 |
| Merck & Co., Inc. | 31 Dec, 2025 | 10,027 | 0 | 0.00% | $38,905.00 |
| UBS Group AG | 31 Dec, 2025 | 1,652 | -516 | -23.80% | $6,409.00 |
| Tower Research Capital LLC (TRC) | 31 Dec, 2025 | 1,400 | 990 | 241.46% | $5,432.00 |
| RHUMBLINE ADVISERS | 31 Dec, 2025 | 202 | 169 | 512.12% | $783.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 58 | 51 | 728.57% | $225.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 17 | 0 | 0.00% | $66.00 |